12 results · 29ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Single-use Sterile High-pressure Angiographic Syringes and Accessories

FDA 510(k)
FDA Class 2 ·Cardiovascular

SpheRx

FDA UDI
Nuvasive, Inc.·00887517443120·SpheRx® II Hook, 10mm Lamina Wide

APERIO EPATHOLOGY EIHC IVD SYSTEM

FDA 510(k)
FDA Class 2 ·Hematology

ZIMMER ANATOMIC II HIP PROSTHESIS

FDA 510(k)
FDA Class 2 ·Orthopedic

ALARIS SYSTEM

FDA Adverse Event
Malfunction ·CAREFUSION SD·Product code FRN·October 27, 2023

BD CONVENTIONAL NEEDLES

FDA Adverse Event
Malfunction ·BECTON DICKINSON, S.A.·Product code FMI·May 13, 2025

TRILOGY AB ACETABULAR SYSTEM ALTERNATE BEARING SHELL INSERT

FDA Adverse Event
Injury ·ZIMMER, INC.·Product code KWB·November 21, 2008

9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·August 17, 2011

LD304 MATERNITY BED

FDA Adverse Event
Malfunction ·STRYKER MEDICAL-KALAMAZOO·Product code HDD·July 22, 2013

TRUE METRIX AIR

FDA Adverse Event
Injury ·TRIVIDIA HEALTH INC·Product code NBW·March 17, 2023

BIOMET StageOne, Shoulder Cement Spacer Mold 10 MM, 50 X 21 X 57 MM, Silicone, Sterile, Item 431410.

FDA Enforcement
Class II ·Terminated·Biomet, Inc.·April 15, 2020

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014